An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy-Reference-Cited by-同舟云学术

An Injectable Hydrogel to Modulate T Cells for Cancer Immunotherapy

Published:2022-07-17 Issue:32 Volume:18 Page:2202663
ISSN:1613-6810
Container-title:Small
language:en
Short-container-title:Small

Author:

Zhang Di¹,Li Qian¹,Chen Xiangwu¹,Nie Xinxin¹,Xue Fumin²^ORCID,Xu Wei³,Luan Yuxia¹^ORCID

Affiliation:

1. NMPA Key Laboratory for Technology Research and Evaluation of Drug Products Key Laboratory of Chemical Biology (Ministry of Education) School of Pharmaceutical Sciences Cheeloo College of Medicine Shandong University 44 West Wenhua Road Jinan 250012 China

2. School of Pharmaceutical Sciences Shandong Analysis and Test Center Qilu University of Technology (Shandong Academy of Sciences) Jinan 250014 China

3. Shandong Provincial Qianfoshan Hospital the First Hospital Affiliated with Shandong First Medical University Jinan 250014 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Biomaterials,Biotechnology,General Materials Science,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/smll.202202663

Reference33 articles.

1. Immune checkpoint inhibitors: The linchpins of modern immunotherapy

2. Tumour burden and efficacy of immune-checkpoint inhibitors